Skip to Main Content

Paper Details

Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort.
Blood Adv
55
2021
Author NameAffiliation
Jean-Baptiste MicolParis-Saclay University
Emmanuel RaffouxHospital Saint-Louis, Assistance Publique-Hopitaux de Paris
Patrick AubergerCote D'Azur University, Mediterranean Center for Molecular Medicine
Lionel Ad??sHospital Saint-Louis, Assistance Publique-Hopitaux de Paris
Lionel Ad??sUniversite de Paris, INSERM U
Thomas CluzeauCote d'Azur University, Centre Hospitalier Universitaire de Nice
Thomas CluzeauCote D'Azur University, Mediterranean Center for Molecular Medicine
  • 1 - 7

Datasets

Release 1.2